Robert E. Sobol
Impact in
- Oncology top 5%
- CAR-T cell therapy research
- Immunology top 5%
- Immunotherapy and Immune Responses
Papers in
- Co-authors
- Ivor Royston (22 shared papers)Daniel L. Shawler (13 shared papers)Habib Fakhrai (11 shared papers)Dan Mercola (6 shared papers)Oliver Dorigo (4 shared papers)Heng-Cheng Lin (1 shared paper)Keith L. Black (1 shared paper)Ruth A. Gjerset (7 shared papers)
- Journals
- Journal of Clinical Oncology (5 papers)Cancer Gene Therapy (2 papers)New England Journal of Medicine (2 papers)Human Gene Therapy (2 papers)Journal of Immunotherapy (2 papers)
- Partner nations
- United StatesCanadaSouth Korea
In The Last Decade
Robert E. Sobol
46 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 86
- Oncology 757
- Immunology 538
- Biotechnology 213
- Hematology 252
- Genetics 212
Countries citing papers authored by Robert E. Sobol
This map shows the geographic impact of Robert E. Sobol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert E. Sobol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert E. Sobol more than expected).
Fields of papers citing papers by Robert E. Sobol
This network shows the impact of papers produced by Robert E. Sobol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert E. Sobol. The network helps show where Robert E. Sobol may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert E. Sobol, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 296 | |
| 2 | 1987 | 286 | |
| 3 | 1991 | 101 | |
| 4 | 1986 | 91 | |
| 5 | 1995 | 87 | |
| 6 | 1989 | 85 | |
| 7 | 1999 | 84 | |
| 8 | 1985 | 79 | |
| 9 | Lack of radioimmunodetection and complications associated with monoclonal anticarcinoembryonic antigen antibody cross-reactivity with an antigen on circulating cells. | 1984 | 78 |
| 10 | Interleukin-2 gene therapy in a patient with glioblastoma. | 1995 | 78 |
| 11 | 1987 | 76 | |
| 12 | 2009 | 70 | |
| 13 | 1995 | 68 | |
| 14 | Interleukin 2 gene therapy of colorectal carcinoma with autologous irradiated tumor cells and genetically engineered fibroblasts: a Phase I study. | 1999 | 60 |
| 15 | 2007 | 44 | |
| 16 | 1987 | 31 | |
| 17 | 1983 | 28 | |
| 18 | 1995 | 27 | |
| 19 | 1998 | 24 | |
| 20 | 2021 | 21 |
About Robert E. Sobol
Robert E. Sobol is a scholar working on Oncology, Genetics, Radiology, Nuclear Medicine and Imaging, Biotechnology and Immunology, having authored 47 papers that have together received 1.9k indexed citations. Recurring topics across this work include Virus-based gene therapy research (16 papers), Cancer Research and Treatments (11 papers), Monoclonal and Polyclonal Antibodies Research (10 papers), Chronic Lymphocytic Leukemia Research (7 papers), Cancer-related Molecular Pathways (6 papers), CAR-T cell therapy research (6 papers), Immunotherapy and Immune Responses (6 papers) and Glycosylation and Glycoproteins Research (5 papers). The work is most often cited by research in Oncology (757 citations), Immunology (538 citations), Biotechnology (213 citations), Hematology (252 citations) and Genetics (212 citations). Robert E. Sobol has collaborated with scholars based in United States, Canada and South Korea. Frequent co-authors include Ivor Royston, Daniel L. Shawler, Habib Fakhrai, Dan Mercola, Oliver Dorigo, Heng-Cheng Lin, Keith L. Black, Ruth A. Gjerset, Clara D. Bloomfield and Leonard J. Deftos. Their work appears in journals such as Journal of Clinical Oncology, Cancer Gene Therapy, New England Journal of Medicine, Human Gene Therapy and Journal of Immunotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.